Status: Recruiting
NG004 in Incomplete Spinal Cord Injury Patients
This is a randomized, double-blind, placebo controlled, multicenter trial of NG004 in patients with acute traumatic incomplete cervical SCI. The trial will evaluate the safety and tolerability, PK, and effects on motor function and daily life functioning of NG004 compared with placebo.
Participants needed: 120
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: NovaGo Therapeutics AGUpdated: Sep 24, 2026Locations: 10
Eligibility criteria
Acute incomplete cervical SCI (Neurological level of injury C1 ≤ lesion ≤ C8) wi... [+3]
Trauma caused by ballistic or other injury that directly penetrates the spinal c... [+15]